Edge Therapeutics (NASDAQ:EDGE)

Edge Therapeutics (NASDAQ:EDGE)


Share Price
0
Change
0 (0 %)
Market Cap
$0.00 m
Proactive Investors - Run By Investors For Investors

Edge Therapeutics

Edge Therapeutics, Inc. is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions. Our product candidates utilize our proprietary Precisa development platform, which allows us to create therapeutics that are...

EPIC: EDGE
Market: NASDAQ:EDGE
col 3
col 4
col 5
col 6

Edge Therapeutics Timeline

Columns Including EDGE

VIEW ALL

Market Reports Including EDGE

VIEW ALL

Videos

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use